One Lambda - Thermo Fisher Scientific

06/05/2026

The lives of transplant patients are forever changed by those who donate their organs, and their stories can serve as an inspiration to more to become donors. Through our “Counting On You” video series, we tell these extraordinary stories.
We are so excited to share that six of these patient story videos have been awarded ! Thank you to all the patients who have shared their stories, and to the teams who prepared these videos to tell them:
🥈 Rebecca’s Story Part 2 Silver – General Branded Content Category
🥈 Carolyn’s Story Silver – General Branded Content Category
🥈 Rebecca’s Story Silver – General Branded Content Category
🥉 Hayden’s Story Bronze – General Sports Category
🥉Carolyn’s Story Bronze – General Sports Category
🥉 Rebecca’s Story Bronze – General B2B: Business-to-Business Category

View all the winners here: https://www.tellyawards.com/winners/

06/04/2026

Expanded HLA-DQ representation continues to drive important conversations in HLA antibody assessment workflows.

Join members of the team behind LABScreen Single Antigen ExPlex for a practical discussion on interpreting HLA-DQ antibody patterns, workflow considerations, and software-assisted analysis strategies. Save My Spot: https://event.on24.com/wcc/r/5370722/32FE5B739DAE7F9C2D26EA80D6A4C54A?partnerref=social&utm_source=linkedin&utm_medium=social&utm_campaign=5370722&utm_content=register-now

📅 June 18, 2026 | 8:00 AM PT

What You’ll Learn
• Why expanded DQ coverage matters
• How DQ antibody patterns can impact interpretation
• Workflow considerations for antibody assessment
• Practical application of software-assisted analysis tools

06/03/2026

A recently published health economic analysis evaluated the potential impact that gene expression–based pre-transplant risk stratification may have on the clinical and economic burden associated with early acute rejection and over-immunosuppression.
Learn more here: https://jheor.org/article/146282-cost-impact-of-a-novel-pre-transplant-risk-assessment-tool-for-early-acute-rejection-in-kidney-transplant-patients

05/29/2026

Watch the on-demand webinar hosted by Thermo Fisher Scientific on donor-derived cell-free DNA (dd-cfDNA) research in pediatric heart transplantation.
Watch On Demand: https://event.on24.com/wcc/r/5326689/822B5198595E425B98399F882A3BE4CB?partnerref=social&utm_source=linkedin&utm_medium=social&utm_campaign=5326689&utm_content=register-now
Missed our live session?

The full recording is now available in the Transplant Diagnostics Webinars on-demand portal.

This session features research insights from Silvia Deaglio, MD, PhD (University of Turin) and highlights real-world experience and operational considerations, including:
• Research applications of dd-cfDNA in heart transplantation
• Single-center, research pediatric transplant data
• Laboratory workflows and operational models supporting dd-cfDNA research

This on-demand webinar is geared toward transplant clinicians, transplant immunology and HLA laboratory professionals, and laboratory decision-makers involved in pediatric heart transplant research and workflow evaluation.

05/28/2026

How is precision medicine reshaping transplant outcomes?

In our latest blog, Alexander “Sasha” Vlassov (Director, R&D, Thermo Fisher Scientific) weighs in on the evolution of post-transplant management. He explores how leveraging advances in immune monitoring and molecular diagnostics allows the community to move away from uniform protocols and toward truly individualized therapeutic strategies.

How is your institution approaching patient-specific immune responses today? Read Sasha's full perspective and share your thoughts below: https://www.thermofisher.com/blog/clinical-conversations/from-one-size-fits-all-to-precision-care-personalizing-therapy-in-transplantation/?cid=0so_fbk_26052026_L07CYH

By: Alexandre “Sasha” Vlassov, Director, R&D, Thermo Fisher Scientific Introduction: Precision Medicine Medicine has traditionally followed a “one-size-fits-all” paradigm, where patients with the same diagnosis receive similar treatments based on population averages derived from clinical tri...

05/28/2026

👋 Meet the Team: Introducing Our Technical Training Experts
This week, we’re excited to spotlight:
James Jones, MSc, BSHI Dip
Senior Technical Training Specialist – Antibody
20 years in HLA

James brings two decades of HLA experience and a passion for collaborative learning, helping laboratories strengthen both workflow efficiency and data analysis skills through hands-on education.

“HLA is important to me because the work we do can truly change lives. Even though we may not meet patients face-to-face, we follow their stories through their samples and outcomes, creating a meaningful connection to our work. It’s also a field that is constantly evolving, with endless opportunities to learn and collaborate.”

Thinking about joining a technical workshop this year?
Here’s James’ perspective:
• Gain hands-on experience with workflows and guided data analysis
• Learn practical approaches to troubleshooting common challenges
• Discover new ideas to improve efficiency and accuracy in your lab

Explore upcoming workshops with James and join us for an interactive learning experience designed for HLA professionals.
https://www.thermofisher.com/us/en/home/clinical/transplant-solutions/onelambda-education.html?cid=0so_lnk_26052026_5TR20M

05/28/2026

AI's role in transplant diagnostics continues to evolve, and its adoption in this field is often more measured due to regulatory, clinical and validation requirements. Tina Liedtky, our president of transplant diagnostics, explores why in her latest article published in MedCity News.

Tina explains that models, workflows, and outputs are typically validated, documented and implemented with appropriate safeguards before being integrated into clinical care. From detecting patterns in complex data to supporting diagnostic workflows, AI has the potential to contribute to improvements in efficiency in transplant medicine. AI may offer meaningful benefits in future transplant diagnostics; however, when patient lives are involved, careful evaluation and implementation are essential.
The future of more personalized transplant care depends on getting this right.

Read Tina's full article here: https://medcitynews.com/2026/05/ai-in-transplant-diagnostics-turning-complexity-into-clinical-clarity/

The strongest AI adoption plans follow a simple pattern: start small, validate and scale only when results hold up across sites, shifts and real-world variation. The goal is safer, more personalized care, which is made possible by clinicians receiving earlier signals, better-tailored monitoring and....

05/26/2026

Join us this July in Panama City for a week-long Advanced HLA Workshop designed for experienced technologists, lab leads, and field specialists looking to build their skills with the Transplant Diagnostics HLA Portfolio and One Lambda Assays.

Learning Objectives:
▪️ A detailed understanding of assay principles and workflows
▪️ Advanced data analysis techniques using specialized software
▪️ Practical strategies for troubleshooting and supporting optimization of assay performance
▪️ Experience working through complex case studies and real-world scenarios
▪️ Insights into pre- and post-transplant applications and donor-recipient compatibility
▪️ Exposure to emerging methodologies and best practices in transplant diagnostics

Register Today: https://web.cvent.com/event/b97658e7-6e73-48a3-a0f5-2e9e05a22349/summary?utm_campaign=LATAM%2520user%2520workshop&utm_medium=website&utm_source=Educational%2520Page

05/26/2026

Thank you to everyone who joined us at the 32nd Congress of the Scandinavian Transplantation Society last week!

With inspiring keynote speakers, thought-provoking symposia, and cutting-edge research presentations, the scientific programme provided a strong platform for learning, discussion, and collaboration across the Nordic transplant community.